What are the key success factors for this endeavor — the combined OpCo + Fund + AI-native Research Lab — to genuinely succeed over the next three years (target horizon: mid-2029)?

What are the key success factors for this endeavor — the combined OpCo + Fund + AI-native Research Lab — to genuinely succeed over the next three years (target horizon: mid-2029)? Evaluate "success" along two axes, separately: 1. **Enterprise success.** The fund actually closes, the lab actually ships, the architecture works, and by mid-2029 the venture has either (a) deployed and returned capital on a credible Fund I track record, or (b) demonstrated a clearly externalizable Aladdin/Venn-shape lab, or ideally both. 2. **My personal success.** I have meaningful equity and/or carry that is vested or in clear sight, the role expanded with the business rather than getting eclipsed, the work materially advanced my AI-consulting practice or set up a venture-scale next move, and the relationship with Rajiv survived the deal. ## Specifically Address - The strategic, structural, and execution decisions made in the first 6–12 months that will most determine whether this works. - The dependencies likeliest to break the thesis if mishandled: LP base quality, asset class clarity, Rajiv's verifiable track record, the closed-loop architecture, competitive density vs. funda and internal hedge-fund AI teams, team build, IP ownership of my prior work. - What "looks fine on paper" but kills 3-year outcomes for ventures of this shape (first-time fund + captive tech operation + non-technical founder + technical co-founder). - Where I hold unique leverage entering this deal, and how to convert that leverage into terms. - A short verdict per axis on the conditions under which I should commit deeply, participate lightly, or decline. ## Ground Rules Adversarial perspectives are welcome and encouraged. I'd rather hear sharp disagreements among the panel than a smoothed consensus. If any panelist believes the entire premise is flawed, say so directly.